Higher dosing of rifamycins does not increase activity against M. tuberculosis in the hollow fibre infection model. Pieterman ED, van den Berg S, van der Meijden A, Svensson EM, et al. Antimicrob Agents Chemother 2021 Feb 8. pii: AAC.02255.

Read + Share

Amedeo Smart

Independent Medical Education

Pieterman ED, van den Berg S, van der Meijden A, Svensson EM, et al. Higher dosing of rifamycins does not increase activity against M. tuberculosis in the hollow fibre infection model. Antimicrob Agents Chemother 2021 Feb 8. pii: AAC.02255.
PMID: 33558283